These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
402 related items for PubMed ID: 23399379
1. High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes. Kaliki S, Shields CL, Rojanaporn D, Al-Dahmash S, McLaughlin JP, Shields JA, Eagle RC. Ophthalmology; 2013 May; 120(5):997-1003. PubMed ID: 23399379 [Abstract] [Full Text] [Related]
2. Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma. Kaliki S, Shields CL, Shah SU, Eagle RC, Shields JA, Leahey A. Arch Ophthalmol; 2011 Nov; 129(11):1422-7. PubMed ID: 22084213 [Abstract] [Full Text] [Related]
3. A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan. Yousef YA, Hajja Y, Nawaiseh I, Mehyar M, Sultan I, Deebajah R, Rawashdeh K, Khurma S, Jaradat I, Al-Hussaini M. Turk Patoloji Derg; 2014 Nov; 30(3):171-7. PubMed ID: 24913302 [Abstract] [Full Text] [Related]
6. PREDICTIVE VALUE OF TNM CLASSIFICATION, INTERNATIONAL CLASSIFICATION, AND REESE-ELLSWORTH STAGING OF RETINOBLASTOMA FOR THE LIKELIHOOD OF HIGH-RISK PATHOLOGIC FEATURES. Yousef YA, Al-Hussaini M, Mehyar M, Sultan I, Jaradat I, AlRawashdeh K, Khurma S, Deebajah R, Nawaiseh I. Retina; 2015 Sep; 35(9):1883-9. PubMed ID: 25923953 [Abstract] [Full Text] [Related]
10. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma. Shields CL, Manjandavida FP, Lally SE, Pieretti G, Arepalli SA, Caywood EH, Jabbour P, Shields JA. Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794 [Abstract] [Full Text] [Related]
11. A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country. Kashyap S, Sethi S, Meel R, Pushker N, Sen S, Bajaj MS, Chandra M, Ghose S. Arch Pathol Lab Med; 2012 Feb; 136(2):190-3. PubMed ID: 22288967 [Abstract] [Full Text] [Related]
12. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma. Shields CL, Kaliki S, Shah SU, Bianciotto CG, Liu D, Jabbour P, Griffin GC, Shields JA. Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042 [Abstract] [Full Text] [Related]
13. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes. Shields CL, Ramasubramanian A, Thangappan A, Hartzell K, Leahey A, Meadows AT, Shields JA. Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557 [Abstract] [Full Text] [Related]
15. Clinical predictors of high risk histopathology in retinoblastoma. Kashyap S, Meel R, Pushker N, Sen S, Bakhshi S, Sreenivas V, Sethi S, Chawla B, Ghose S. Pediatr Blood Cancer; 2012 Mar; 58(3):356-61. PubMed ID: 21721113 [Abstract] [Full Text] [Related]
16. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation. Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO. Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557 [Abstract] [Full Text] [Related]